Ahmed, Ashraf OE and Okotcha, Edmond and Saad, Abdul-Hussein (2021) Gemfibrozil-Induced Polyuria. European Journal of Case Reports in Internal Medicine, 8 (4). pp. 1-3. ISSN ISSN: 2284-2594
|
Text
2546-Article Text-22160-1-10-20210426.pdf - Published Version Download (230kB) | Preview |
Abstract
Gemfibrozil is a lipid-regulating agent used mainly to treat patients with hypertriglyceridaemia, especially those at risk for acute pancreatitis. Like any other pharmacological agent, gemfibrozil has known adverse effects, mainly gastrointestinal, such as cholelithiasis, gallstones, elevated transaminase, and other non-specific symptoms including dyspepsia, nausea and vomiting. Other reported adverse reactions are dizziness and vertigo, myopathy and rhabdomyolysis, angioedema, urticaria and rash. As far as we knew, gemfibrozil does not have urinary tract adverse reactions. In this report, we present a case of polyuria secondary to gemfibrozil with a score of 9 on the Naranjo scale, and a literature review.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Gemfibrozil, anti-hyperlipidaemic, urinary side effects, polyuria |
| Subjects: | 600 Tecnologia - Scienze applicate 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale) |
| Depositing User: | Marina Spanti |
| Date Deposited: | 21 Dec 2021 14:59 |
| Last Modified: | 21 Dec 2021 14:59 |
| URI: | http://eprints.bice.rm.cnr.it/id/eprint/21218 |
Actions (login required)
 |
View Item |
